Advanced PCa Treatment Webinar

Dr. Beer presented at last weekend's PCRI conference a study of new applications of Zytiga and Xtandi. Promising stuff, but the cost of the drugs is prohibitive unless you are mCRPC.

The challenge is to get on Zytiga and Xtandi, early and possibly avoid mCRPC altogether.

The research he does is largely funded by the Nike shoe company, so kudos to them.

-----------------------------------------------------------------------------

12/02 PSA 2.9 age 51
9/03 BX/DX, Gleason 6, 4 of 12 cores
9/03 Brachytherapy
5/08 PSA nadir 1.1
12/08 PSA 1.8
2/09 BX/DX, Gleason 8, 1 of 12 cores
6/09 Hyperthermic Radiation, Hormone (short term), IMRT (10 fractions) spring 2009
10/09 PSA nadir < 0.1 10/09 through 01/12
4/12 PSA 0.2
3/14 PSA 2.9
5/14 C11 Acetate PT/CT, found 2.0 cm lymph node
5/14 Lupron/Casodex (9 months)
8/14 nadir <0.01
2/15 SBRT to node, at UCSD
3/15 PSA 0.02,T=0
6/15 PSA<0.015,T=105 (yippee!)